{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T15:49:06Z","timestamp":1764172146246,"version":"build-2065373602"},"reference-count":66,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.ecl.2015.07.006","type":"journal-article","created":{"date-parts":[[2015,8,24]],"date-time":"2015-08-24T20:43:10Z","timestamp":1440448990000},"page":"787-797","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Reproductive System Outcome Among Patients with Polycystic Ovarian Syndrome"],"prefix":"10.1016","volume":"44","author":[{"given":"Enrico","family":"Carmina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ecl.2015.07.006_bib1","series-title":"Polycystic ovary syndrome","first-page":"377","article-title":"Diagnostic criteria for polycystic ovary syndrome: towards a rationale approach","author":"Zawadzki","year":"1992"},{"key":"10.1016\/j.ecl.2015.07.006_bib2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0015-0282(98)00455-5","article-title":"Do hyperandrogenic women with normal menses have polycystic ovary syndrome?","volume":"71","author":"Carmina","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2015.07.006_bib3","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S0002-9343(01)00979-2","article-title":"Polycystic ovaries in women with normal menses","volume":"111","author":"Carmina","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.ecl.2015.07.006_bib4","first-page":"53","article-title":"Diagnosing PCOS in women who menstruate regularly","volume":"48","author":"Carmina","year":"2003","journal-title":"Contemporary OB\/GYN"},{"key":"10.1016\/j.ecl.2015.07.006_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Rotterdam ESHRE\/ASRM Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2015.07.006_bib6","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"10.1016\/j.ecl.2015.07.006_bib7","first-page":"87","article-title":"Diagnosis, phenotype and prevalence of polycystic ovary syndrome","volume":"86","author":"Carmina","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2015.07.006_bib8","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1210\/jc.2006-1327","article-title":"Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features","volume":"91","author":"Welt","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2015.07.006_bib9","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.fertnstert.2006.02.069","article-title":"The spectrum of androgen excess disorders","volume":"85","author":"Carmina","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2015.07.006_bib10","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2015.07.006_bib11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1210\/jc.2005-1457","article-title":"Relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism","volume":"91","author":"Carmina","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2015.07.006_bib12","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/humrep\/dep399","article-title":"The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria","volume":"25","author":"March","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ecl.2015.07.006_bib13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1477-7827-9-39","article-title":"The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study","volume":"9","author":"Tehrani","year":"2011","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.ecl.2015.07.006_bib14","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1093\/humrep\/des232","article-title":"Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria","volume":"27","author":"Yildiz","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ecl.2015.07.006_bib15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ng.732","article-title":"Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3","volume":"43","author":"Chen","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.ecl.2015.07.006_bib16","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1055\/s-0034-1371089","article-title":"Genetics of polycystic ovary syndrome","volume":"32","author":"Welt","year":"2014","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.ecl.2015.07.006_bib17","doi-asserted-by":"crossref","first-page":"E182","DOI":"10.1210\/jc.2014-2689","article-title":"Further investigation in Europeans of susceptibility variants for polycystic ovary syndrome discovered in genome-wide association studies of Chinese individuals","volume":"100","author":"Brower","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2015.07.006_bib18","doi-asserted-by":"crossref","first-page":"E1519","DOI":"10.1073\/pnas.1400574111","article-title":"Overexpression of a DENND1A isoform produces a polycystic ovary syndrome theca phenotype","volume":"111","author":"McAllister","year":"2014","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.ecl.2015.07.006_bib19","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.tem.2014.12.004","article-title":"Functional genomics of PCOS: from GWAS to molecular mechanisms","volume":"26","author":"McAllister","year":"2015","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.ecl.2015.07.006_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/er.2014-1020","article-title":"Intraovarian control of early folliculogenesis","volume":"36","author":"Hsueh","year":"2015","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ecl.2015.07.006_bib21","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.beem.2006.02.001","article-title":"Mild androgen disorders","volume":"20","author":"Carmina","year":"2006","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2015.07.006_bib22","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/j.fertnstert.2010.02.014","article-title":"Clinical and endocrine characteristics of the main PCOS phenotypes","volume":"94","author":"Guastella","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2015.07.006_bib23","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199509283331307","article-title":"Polycystic ovary syndrome","volume":"333","author":"Franks","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ecl.2015.07.006_bib24","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/humupd\/dmn015","article-title":"Follicle dynamics and anovulation in polycystic ovary syndrome","volume":"14","author":"Franks","year":"2008","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ecl.2015.07.006_bib25","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/oxfordjournals.humrep.a137638","article-title":"Granulosa cells in polycystic ovaries: are they normal or abnormal?","volume":"7","author":"Erickson","year":"1992","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ecl.2015.07.006_bib26","first-page":"1355","article-title":"Estradiol production by granulosa cells of normal and polycystic ovaries: relationship to menstrual cycle history and concentrations of gonadotropins and sex steroids in follicular fluid","volume":"79","author":"Mason","year":"1994","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2015.07.006_bib27","first-page":"3984","article-title":"Premature response to luteinizing hormone of granulosa cells from anovulatory women with polycystic ovary syndrome: relevance to the mechanism of anovulation","volume":"83","author":"Willis","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2015.07.006_bib28","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/humrep\/des424","article-title":"Genotype-phenotype correlations of PCOS susceptibility SNPs identified by GWAS in a large cohort of Han Chinese women","volume":"28","author":"Cui","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ecl.2015.07.006_bib29","first-page":"1470","article-title":"Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone","volume":"84","author":"Huber-Buckholz","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2015.07.006_bib30","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1210\/jc.2008-1492","article-title":"Polycystic ovary syndrome is associated with tissue-specific differences in insulin resistance","volume":"94","author":"Ciaraldi","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2015.07.006_bib31","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/humrep\/deh609","article-title":"Impaired insulin-dependent glucose metabolism in granulosa-lutein cells from anovulatory women with PCOS","volume":"20","author":"Rice","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ecl.2015.07.006_bib32","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/00001648-199907000-00014","article-title":"Fecundability in relation to body mass and menstrual cycle patterns","volume":"10","author":"Jensen","year":"1999","journal-title":"Epidemiology"},{"key":"10.1016\/j.ecl.2015.07.006_bib33","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S1472-6483(10)61179-0","article-title":"Metabolic effects of obesity on reproduction","volume":"12","author":"Pasquali","year":"2006","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ecl.2015.07.006_bib34","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1210\/jc.2006-2725","article-title":"Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance","volume":"92","author":"Carmina","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2015.07.006_bib35","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1210\/jc.2006-1054","article-title":"Oligoanovulation and polycystic ovaries but no overt hyperandrogenism","volume":"91","author":"Dewailly","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2015.07.006_bib36","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/humrep\/des460","article-title":"Loss of LH-induced down-regulation of anti-M\u00fcllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome","volume":"28","author":"Pierre","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ecl.2015.07.006_bib37","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/19396368.2014.973123","article-title":"The relationship between serum anti-M\u00fcllerian hormone levels and the follicular arrest for women with polycystic ovary syndrome","volume":"61","author":"Li","year":"2015","journal-title":"Syst Biol Reprod Med"},{"key":"10.1016\/j.ecl.2015.07.006_bib38","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00404-014-3317-2","article-title":"Anti-Mullerian hormone: an indicator for the\u00a0severity of polycystic ovarian syndrome","volume":"290","author":"K\u00f6ninger","year":"2014","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ecl.2015.07.006_bib39","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/humrep\/15.1.24","article-title":"Women with polycystic ovary\u00a0syndrome gain regular menstrual cycles when ageing","volume":"15","author":"Elting","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ecl.2015.07.006_bib40","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.fertnstert.2011.09.002","article-title":"The phenotype of polycystic ovary syndrome ameliorates with aging","volume":"96","author":"Brown","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2015.07.006_bib41","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/AOG.0b013e31823f7135","article-title":"A\u00a020-year follow-up of young women with polycystic ovary syndrome","volume":"119","author":"Carmina","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ecl.2015.07.006_bib42","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1093\/humrep\/det119","article-title":"Emergence of ovulatory cycles with aging in women with polycystic ovary syndrome (PCOS) alters the trajectory of cardiovascular and metabolic risk factors","volume":"28","author":"Carmina","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ecl.2015.07.006_bib43","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1210\/jcem.82.8.4160","article-title":"Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging","volume":"82","author":"Labrie","year":"1997","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2015.07.006_bib44","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1210\/jc.2002-021549","article-title":"Ovarian age-related responsiveness to human chorionic gonadotropin","volume":"88","author":"Piltonen","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2015.07.006_bib45","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1006\/gyno.2000.5783","article-title":"Ovarian volume related to age","volume":"77","author":"Pavlik","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ecl.2015.07.006_bib46","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00042192-200310030-00006","article-title":"Ovarian volume in pre- and perimenopausal women: a population-based study","volume":"10","author":"Oppermann","year":"2003","journal-title":"Menopause"},{"key":"10.1016\/j.ecl.2015.07.006_bib47","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0015-0282(98)00536-6","article-title":"Adrenal androgen excess in hyperandrogenism: relation to age and body mass","volume":"71","author":"Mor\u00e1n","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2015.07.006_bib48","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jsbmb.2014.06.003","article-title":"DHEA, DHEAS and PCOS","volume":"145","author":"Goodarzi","year":"2015","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"10.1016\/j.ecl.2015.07.006_bib49","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1093\/humrep\/der302","article-title":"Clinical and biochemical presentation of polycystic ovary syndrome in women between the ages of 20 and 40","volume":"26","author":"Liang","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ecl.2015.07.006_bib50","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0015-0282(99)00641-X","article-title":"Serum testosterone levels decrease in\u00a0middle age in women with the polycystic ovary syndrome","volume":"73","author":"Winters","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2015.07.006_bib51","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1034\/j.1600-0412.1999.780212.x","article-title":"The prevalence of polycystic ovaries in healthy women","volume":"78","author":"Koivunen","year":"1999","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ecl.2015.07.006_bib52","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.fertnstert.2012.06.017","article-title":"Does the level of serum antim\u00fcllerian hormone predict ovulatory function in women with polycystic ovary syndrome with aging?","volume":"98","author":"Carmina","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2015.07.006_bib53","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1093\/humrep\/deq088","article-title":"Is polycystic ovary syndrome an exception for reproductive aging?","volume":"25","author":"Tehrani","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ecl.2015.07.006_bib54","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1093\/humrep\/deh850","article-title":"Serum anti-Mullerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome","volume":"20","author":"Piltonen","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ecl.2015.07.006_bib55","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.fertnstert.2013.02.055","article-title":"Is the fertile window extended in women with polycystic ovary syndrome? Utilizing the Society for Assisted Reproductive Technology registry to assess the impact of reproductive aging on live-birth rate","volume":"100","author":"Kalra","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ecl.2015.07.006_bib56","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1479-828X.2012.01448.x","article-title":"The treatment of infertility in polycystic ovary syndrome: a brief update","volume":"52","author":"Costello","year":"2012","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.ecl.2015.07.006_bib57","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nrendo.2014.102","article-title":"The management of patients with polycystic ovary syndrome","volume":"10","author":"Jayasena","year":"2014","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"10.1016\/j.ecl.2015.07.006_bib58","article-title":"Aromatase inhibitors for subfertile women with polycystic ovary syndrome","author":"Franik","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ecl.2015.07.006_bib59","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1056\/NEJMoa1313517","article-title":"Letrozole versus clomiphene for infertility in the polycystic ovary syndrome","volume":"371","author":"Legro","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ecl.2015.07.006_bib60","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1056\/NEJMoa063971","article-title":"Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome","volume":"356","author":"Legro","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ecl.2015.07.006_bib61","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.steroids.2013.05.005","article-title":"Ovulation induction in women with polycystic ovary syndrome","volume":"78","author":"Perales-Puchalt","year":"2013","journal-title":"Steroids"},{"key":"10.1016\/j.ecl.2015.07.006_bib62","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1093\/humrep\/den182","article-title":"Does adding metformin to clomifene citrate lead to higher pregnancy rates in a subset of women with polycystic ovary syndrome?","volume":"23","author":"Moll","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ecl.2015.07.006_bib63","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.tem.2012.07.001","article-title":"Status of clomiphene citrate and metformin for infertility in PCOS","volume":"23","author":"Misso","year":"2012","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.ecl.2015.07.006_bib64","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/humupd\/5.5.493","article-title":"Low-dose FSH therapy for anovulatory infertility associated with PCOS: rationale, reflections and refinements","volume":"5","author":"Homburg","year":"1999","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ecl.2015.07.006_bib65","first-page":"40","article-title":"Laparoscopic ovarian drilling: an alternative but not the ultimate in the management of polycystic ovary syndrome","volume":"6","author":"Mitra","year":"2015","journal-title":"J\u00a0Nat Sci Biol Med"},{"key":"10.1016\/j.ecl.2015.07.006_bib66","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2217\/WHE.12.7","article-title":"Evidence-based management of infertility in women with polycystic ovary syndrome using surgery or assisted reproductive technology","volume":"8","author":"Costello","year":"2012","journal-title":"Womens Health (Lond Engl)"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852915000821?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852915000821?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:40:42Z","timestamp":1760175642000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852915000821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0889852915000821"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2015.07.006","relation":{},"ISSN":["0889-8529"],"issn-type":[{"type":"print","value":"0889-8529"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reproductive System Outcome Among Patients with Polycystic Ovarian Syndrome","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2015.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}